Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Xenon Pharmaceuticals Insider Bought Shares Worth $1,121,400, According to a Recent SEC Filing

Xenon Pharmaceuticals Insider Bought Shares Worth $1,121,400, According to a Recent SEC Filing

MT newswireMT newswire2026/10/01 13:23
09:23 AM EDT, 10/01/2026 (MT Newswires) -- Ian Mortimer, Director, President and Chief Executive Officer, on September 30, 2026, executed a purchase for 30,000 shares in Xenon Pharmaceuticals (XENE) for $1,121,400. Following the Form 4 filing with the SEC, Mortimer has control over a total of 64,223 common shares of the company, with 49,923 shares held directly and 14,300 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1582313/000119312526409999/xslF345X05/ownership.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!